NuraLogix announces new AI model for fatty liver disease
NuraLogix has announced new capability for assessing fatty liver disease risk, using its contactless health platform that measures vital signs and provides health risk assessments.The company’s researchers have developed artificial intelligence (AI) models that…
Continue Reading